ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY
Clinical trials for ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY explained in plain language.
Never miss a new study
Get alerted when new ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY trials appear
Sign up with your email to follow new studies for ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Stent may prevent pancreatitis after tough ERCP procedure
Disease control Recruiting nowThis study looks at whether placing a small tube (stent) in the pancreas can lower the chance of pancreatitis after a difficult bile duct procedure. About 268 adults needing ERCP will be randomly assigned to get a stent or not. The main goal is to see if the stent reduces post-pr…
Matched conditions: ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY
Phase: NA • Sponsor: Helsinki University Central Hospital • Aim: Disease control
Last updated May 15, 2026 11:57 UTC
-
Zapping away sedation risks: new trial tests acupoint stimulation for ERCP
Symptom relief Recruiting nowThis study tests if a gentle electrical current applied to specific points on the skin (TEAS) can reduce side effects from sedation during a digestive procedure called ERCP. About 130 adults will receive either real or fake TEAS alongside standard sedation. Researchers will measu…
Matched conditions: ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY
Phase: NA • Sponsor: Beijing 302 Hospital • Aim: Symptom relief
Last updated May 17, 2026 03:58 UTC
-
Breathe away the pain: box breathing tested for ERCP patients
Symptom relief Recruiting nowThis study tests whether a simple breathing technique called box breathing can help reduce anxiety, pain, and nausea in adults undergoing a medical procedure called ERCP. About 70 participants will be randomly assigned to either receive standard care plus box breathing training o…
Matched conditions: ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY
Phase: NA • Sponsor: Acibadem University • Aim: Symptom relief
Last updated May 13, 2026 16:01 UTC